The phenotypic landscape of p.Ala117Ser transthyretin amyloidosis: distinct clinical profiles and outcomes versus wild-type ATTR
Phakin Tuntiwongkosee, Patchara Kochaiyapatana, Prasit Phowthongkum, Jakkrit Amornvit, Khanidta Saicharoen, Pairoj Chattranukulchai, Krailerk Chettakulanurak, Sarinya Puwanant · 2025
Read The phenotypic landscape of p.Ala117Ser transthyretin amyloidosis: distinct clinical profiles and outcomes versus wild-type ATTR by Phakin Tuntiwongkosee, Patchara Kochaiyapatana, Prasit Phowthongkum, Jakkrit Amornvit, Khanidta Saicharoen, Pairoj Chattranukulchai, Krailerk Chettakulanurak, Sarinya Puwanant (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12829060.txt.
Description
Phakin Tuntiwongkosee and colleagues compare two forms of transthyretin amyloidosis at one center. Their observational study from twenty twenty-five focuses on the p.Ala117Ser variant. That inherited form is set against wild-type disease. Patients received structured checks in a cardiomyopathy clinic.
Fifty people took part, including seven carriers without symptoms. Inherited disease made up just over half the group. The named variant was the most common inherited cause found. Symptomatic carriers were younger than wild-type patients. They all had nerve involvement but less advanced heart disease. Their event-free survival over three years was higher. The study maps how this variant differs in daily clinical practice.
Catalog record
| CREATOR | Phakin Tuntiwongkosee, Patchara Kochaiyapatana, Prasit Phowthongkum, Jakkrit Amornvit, Khanidta Saicharoen, Pairoj Chattranukulchai, Krailerk Chettakulanurak, Sarinya Puwanant |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |